• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

2019 FSA Posters

2019 FSA Posters

P010: PREDICTIVE VALUE OF NON-INVASIVE CARDIAC TESTING FOR PREOPERATIVE CORONARY REVASCULARIZATION AND ADVERSE CARDIAC EVENTS 30-DAYS POST KIDNEY TRANSPLANT
Nicholas V Mendez, MD, Raveh Yehuda, MD, Vadim Shatz, MD, Ramona Nicolau-Raducu, MD, PhD; University of Miami Miller School of Medicine

Introduction: Renal transplantation is associated with adverse perioperative cardiovascular outcomes and pretransplant cardiac evaluation is, therefore, indicated for high-risk candidates. The predictive value of non-invasive stress testing for preoperative coronary revascularization, and adverse outcomes in this high risk group is not well established.

Methods: After an IRB approval, out of 313 cadaveric kidneys transplanted between January 2016 to July 2017, we retrospectively identified 52 recipients whose pretransplant cardiac workup included both routine non-invasive stress (regadenoson nuclear 49; dobutamine 2; exercise stress test 1) and coronary angiography (18- due to positive stress test & 34- due to ≥3 risk factors for coronary artery disease). Pretransplant coronary revascularization was required in 33% (17/52; 14 percutaneous and 3 surgical coronary revascularization).

Results: Non-invasive testing had low sensitivity (47%) & positive predictive value (44%), and intermediate specificity (71%) & negative predictive value (74%) for detection of severe coronary artery stenosis (≥ 70%), Table 1. In the first post-transplant month, 11 adverse cardiac events (1 non-fatal and 1 fatal myocardial infarction, 5 atrial fibrillation, 4 pulmonary edema) occurred in 13% (7/52) of recipients. Preoperative non-invasive stress testing and coronary revascularization had an intermediate specificity (64%) and a relatively high negative predictive value (>80%) for prediction of 30-days post kidney transplant adverse cardiac events in high risk recipients, Table 1.

Conclusion: Preoperative revascularization does not fully protect against adverse cardiac outcomes; a positive non-invasive stress test result is not reliably indicative of an increased cardiac risk, but a negative result is strongly predictive of an uneventful posttransplant cardiovascular course.

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved